- Research works
- 95 ▲ 96% vs 2013–17
- Citations
- 6.8k 71.8 per fractional work
- Top-10% rate
- 9.1% record average 16.5%
- Open access
- 24% world 28%
Not ranked overall: Inimex Pharmaceuticals (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 7.1×. Every wedge is a field page.
- Economics, Econometrics and Finance 7.1×
- Business, Management and Accounting 5.4×
- Pharmacology, Toxicology and Pharmaceutics 5.1×
- Decision Sciences 4.5×
- Neuroscience 2.9×
- Chemistry 2.8×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Medicine 1.5×
- Health Professions 0.8×
- Computer Science 0.6×
- Psychology 0.3×
- Agricultural and Biological Sciences 0.2×
- Social Sciences 0.2×
- Engineering 0.1×
Which keywords describe research at Inimex Pharmaceuticals (Canada)?
By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, RNA Interference, siRNA Delivery, Nanoparticles, Cancer Therapy, Cancer, Membrane Proteins and Cholesterol.
- Genomic Stability
- NK Cell Recognition
- Chemotherapy-Induced Peripheral Neuropathy
- Innate Antiviral Responses
- Pattern Recognition Receptors
- Viral Vectors
- AAV
- Dendritic Cells
- Cancer Immunotherapy
- Nanocarriers
- Immunity
- aptamers
- Drug Delivery
- Innate Immunity
- Membrane Lipids
- Lipid Rafts
- Inflammation
- Cancer Therapy
- Nanoparticles
- RNA Interference
- Gene Therapy
- siRNA Delivery
- Cancer
- Membrane Proteins
- Cholesterol
- Cell Membranes
- Self-Assembly
- Biosensors
- DNA nanotechnology
- Biomedical Applications
- Tumor Targeting
- Surface Engineering
- Antigen Presentation
- Toll-like Receptors
- Apoptosis
- Neurotoxicity
- Cytokine-Mediated Link
- Glycosylation
- Taxanes
- Natural Killer Cells
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Gene Therapy15▲ 59×5 topics
- RNA Interference11▲ 106×1 topic
- siRNA Delivery11▲ 158×1 topic
- Nanoparticles10▲ 7.6×8 topics
- Cancer7▲ 5.5×17 topics
- Cancer Therapy7▲ 11×9 topics
- Membrane Proteins6▲ 35×3 topics
- Inflammation6▲ 2.6×17 topics
- Cholesterol6▲ 32×3 topics
- Lipid Rafts5▲ 80×2 topics
- Cell Membranes5▲ 93×1 topic
- Membrane Lipids5▲ 93×1 topic
- Self-Assembly5▲ 14×4 topics
- Innate Immunity5▲ 15×6 topics
- Biosensors5▲ 8.8×2 topics
- Drug Delivery5▲ 10×5 topics
- DNA nanotechnology4▲ 46×1 topic
- aptamers4▲ 46×1 topic
- Biomedical Applications4▲ 4.3×5 topics
- Immunity4▲ 13×6 topics
- Tumor Targeting4▲ 33×3 topics
- Nanocarriers4▲ 90×1 topic
- Surface Engineering4▲ 34×1 topic
- Cancer Immunotherapy4▲ 27×2 topics
- Antigen Presentation3▲ 36×1 topic
- Dendritic Cells3▲ 31×1 topic
- Toll-like Receptors3▲ 19×2 topics
- AAV3▲ 49×1 topic
- Apoptosis3▲ 8.2×9 topics
- Viral Vectors3▲ 49×1 topic
- Neurotoxicity3▲ 17×4 topics
- Pattern Recognition Receptors3▲ 21×2 topics
- Cytokine-Mediated Link3▲ 42×1 topic
- Innate Antiviral Responses3▲ 42×1 topic
- Glycosylation2▲ 12×3 topics
- Chemotherapy-Induced Peripheral Neuropathy2▲ 51×1 topic
- Taxanes2▲ 51×1 topic
- NK Cell Recognition2▲ 24×1 topic
- Natural Killer Cells2▲ 24×1 topic
- Genomic Stability2▲ 24×2 topics
Which research topics does Inimex Pharmaceuticals (Canada) publish most on?
By volume in 2022–2025: Market Dynamics and Volatility, Law, logistics, and international trade, Cannabis and Cannabinoid Research and PARP inhibition in cancer therapy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Market Dynamics and Volatility Economics and Econometrics 1 works
- 2 Law, logistics, and international trade Accounting 1 works
- 3 Cannabis and Cannabinoid Research Pharmacology 0 works
- 4 PARP inhibition in cancer therapy Oncology 0 works
- 5 FOXO transcription factor regulation Molecular Biology 0 works
- 6 Carbohydrate Chemistry and Synthesis Organic Chemistry 0 works
- 7 Scientific Computing and Data Management Information Systems and Management 0 works
- 8 Signaling Pathways in Disease Molecular Biology 0 works
- 9 Big Data and Business Intelligence Management Information Systems 0 works
- 10 Cloud Computing and Resource Management Information Systems 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Inimex Pharmaceuticals (Canada)'s research output changed?
Output in 2018–2022 was 96% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Burnaby
- Simon Fraser University
- British Columbia Institute of Technology
- Burnaby Hospital
- Microsemi (Canada)
- Alpha Technologies (Canada)
- Delta-Q Technologies (Canada)
- Ballard Power Systems (Canada)
- D-Wave Systems (Canada)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.